Acadian Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-23,346
Closed -$26K 1947
2019
Q2
$26K Buy
+23,346
New +$26K ﹤0.01% 1569